The Effect of Multiple Doses of BI 425809 on the Pharmacokinetics of Multiple Doses of a Combination of Ethinylestradiol and Levonorgestrel Following Oral Administration in Healthy Premenopausal Female Subjects (an Open-label, Two-period, Fixed Sequence Design Trial With run-in Period)
Latest Information Update: 25 Oct 2023
At a glance
- Drugs Iclepertin (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Cognition disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
Most Recent Events
- 02 Oct 2023 Status changed from active, no longer recruiting to completed.
- 08 Sep 2023 Planned End Date changed from 20 Sep 2023 to 25 Sep 2023.
- 08 Sep 2023 Planned primary completion date changed from 20 Sep 2023 to 25 Sep 2023.